These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 9816173)
1. Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea. Philip PA; Souliotis VL; Harris AL; Salisbury A; Tates AD; Mitchell K; van Delft JH; Ganesan TS; Kyrtopoulos SA Clin Cancer Res; 1996 Feb; 2(2):303-10. PubMed ID: 9816173 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of the formation and repair of O6-methylguanine in humans and rodents treated with dacarbazine. Souliotis VL; Valavanis C; Boussiotis VA; Pangalis GA; Kyrtopoulos SA Carcinogenesis; 1996 Apr; 17(4):725-32. PubMed ID: 8625483 [TBL] [Abstract][Full Text] [Related]
3. New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance. Spiro T; Liu L; Gerson S Forum (Genova); 2000; 10(3):274-85. PubMed ID: 11007934 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of procarbazine and methylnitrosourea on the accumulation of O6-methylguanine and the depletion and recovery of O6-alkylguanine-DNA alkyltransferase in rat tissues. Valavanis C; Souliotis VL; Kyrtopoulos SA Carcinogenesis; 1994 Aug; 15(8):1681-8. PubMed ID: 7519972 [TBL] [Abstract][Full Text] [Related]
5. O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study. Middleton MR; Lee SM; Arance A; Wood M; Thatcher N; Margison GP Int J Cancer; 2000 Nov; 88(3):469-73. PubMed ID: 11054678 [TBL] [Abstract][Full Text] [Related]
6. Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblasts. Lukash LL; Boldt J; Pegg AE; Dolan ME; Maher VM; McCormick JJ Mutat Res; 1991; 250(1-2):397-409. PubMed ID: 1944354 [TBL] [Abstract][Full Text] [Related]
7. In vivo formation and repair of O6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine. Souliotis VL; Boussiotis VA; Pangalis GA; Kyrtopoulos SA Carcinogenesis; 1991 Feb; 12(2):285-8. PubMed ID: 1704822 [TBL] [Abstract][Full Text] [Related]
8. A phase II study evaluating the effect of tamoxifen on DNA repair in melanoma patients treated with dacarbazine. Saunders MP; Salisbury AJ; O'Byrne KJ; Souliotis VL; Varcoe SM; Talbot DC; Kyrtopoulos SA; Harris AL Anticancer Res; 1997; 17(6D):4677-80. PubMed ID: 9494588 [TBL] [Abstract][Full Text] [Related]
9. Sequential therapy with dacarbazine and carmustine: a phase I study. Mitchell RB; Dolan ME; Janisch L; Vogelzang NJ; Ratain MJ; Schilsky RL Cancer Chemother Pharmacol; 1994; 34(6):509-14. PubMed ID: 7923562 [TBL] [Abstract][Full Text] [Related]
10. Accumulation of O6-methylguanine in human blood leukocyte DNA during exposure to procarbazine and its relationships with dose and repair. Souliotis VL; Kaila S; Boussiotis VA; Pangalis GA; Kyrtopoulos SA Cancer Res; 1990 May; 50(9):2759-64. PubMed ID: 2328502 [TBL] [Abstract][Full Text] [Related]
11. Dosimetry of O6-methylguanine in rat DNA after low-dose, chronic exposure to N-nitrosodimethylamine (NDMA). Implications for the mechanism of NDMA hepatocarcinogenesis. Souliotis VL; Chhabra S; Anderson LM; Kyrtopoulos SA Carcinogenesis; 1995 Oct; 16(10):2381-7. PubMed ID: 7586139 [TBL] [Abstract][Full Text] [Related]
12. DNA adduct dosimetry and DNA repair in rats and pigs given repeated doses of procarbazine under conditions of carcinogenicity and human cancer chemotherapy respectively. Fong LY; Bevill RF; Thurmon JC; Magee PN Carcinogenesis; 1992 Nov; 13(11):2153-9. PubMed ID: 1423888 [TBL] [Abstract][Full Text] [Related]
13. O6-alkylguanine-DNA alkyltransferase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine. Lee SM; Thatcher N; Margison GP Cancer Res; 1991 Jan; 51(2):619-23. PubMed ID: 1824685 [TBL] [Abstract][Full Text] [Related]
14. Specificity of mutations induced by methyl methanesulfonate in mismatch repair-deficient human cancer cell lines. Glaab WE; Tindall KR; Skopek TR Mutat Res; 1999 Jun; 427(2):67-78. PubMed ID: 10393261 [TBL] [Abstract][Full Text] [Related]
15. The repair of the tobacco specific nitrosamine derived adduct O6-[4-Oxo-4-(3-pyridyl)butyl]guanine by O6-alkylguanine-DNA alkyltransferase variants. Mijal RS; Thomson NM; Fleischer NL; Pauly GT; Moschel RC; Kanugula S; Fang Q; Pegg AE; Peterson LA Chem Res Toxicol; 2004 Mar; 17(3):424-34. PubMed ID: 15025514 [TBL] [Abstract][Full Text] [Related]
16. Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer. Schilsky RL; Dolan ME; Bertucci D; Ewesuedo RB; Vogelzang NJ; Mani S; Wilson LR; Ratain MJ Clin Cancer Res; 2000 Aug; 6(8):3025-31. PubMed ID: 10955780 [TBL] [Abstract][Full Text] [Related]
17. Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma. Lee SM; Margison GP; Woodcock AA; Thatcher N Br J Cancer; 1993 Jun; 67(6):1356-60. PubMed ID: 8512821 [TBL] [Abstract][Full Text] [Related]
18. In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue. Lee SM; Thatcher N; Crowther D; Margison GP Cancer Chemother Pharmacol; 1992; 31(3):240-6. PubMed ID: 1464162 [TBL] [Abstract][Full Text] [Related]
19. Dosage and cycle effects of dacarbazine (DTIC) and fotemustine on O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells. Lee SM; Thatcher N; Dougal M; Margison GP Br J Cancer; 1993 Feb; 67(2):216-21. PubMed ID: 8431354 [TBL] [Abstract][Full Text] [Related]
20. Enhanced repair of O6-methylguanine DNA adducts in the liver of transgenic mice expressing the ada gene. Dumenco LL; Arce C; Norton K; Yun J; Wagner T; Gerson SL Cancer Res; 1991 Jul; 51(13):3391-8. PubMed ID: 2054779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]